You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

infiltrative bladder carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infiltrating Bladder Urothelial Carcinoma Trial in Montpellier (Radiation + cisplatin, Radiation + cisplatin + gemcitabine)

Active, not recruiting
  • Infiltrating Bladder Urothelial Carcinoma
  • Radiation + cisplatin
  • Radiation + cisplatin + gemcitabine
  • Montpellier, France
    CRLC Val d'Aurelle-Paul Lamarque
Dec 20, 2021

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 30, 2023

Unusual Infiltrative Patterns of Malignant Cells in Endometrial

Not yet recruiting
  • Endometrial Cancer
    • (no location specified)
    Mar 11, 2023

    Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

    Not yet recruiting
    • Neuroendocrine Carcinoma of the Bladder
    • Bladder Cancer
    • (no location specified)
    Oct 14, 2023

    Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

    Not yet recruiting
    • Urothelial Carcinoma Bladder
    • Androgen Receptor Positive
    • Providence, Rhode Island
      Lifespan Cancer Institute
    May 1, 2023

    Biomarkers in Bladder Urothelial Carcinoma

    Completed
    • Bladder Cancer
    • Free glycosaminoglycan profiling
    • Gothenburg, Sweden
      Department of Urology, Institute of Clinical Science, Sahlgrensk
    Apr 3, 2023

    Bladder Bank (a Prospective Banking Study)

    Recruiting
    • Bladder Carcinoma
    • Hematuria
    • Non-Interventional Study
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 25, 2023

    Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

    Not yet recruiting
    • Urinary Bladder Neoplasms
      • (no location specified)
      Feb 14, 2023

      Can Second Resection for pT1 Bladder Cancer be Avoided After

      Recruiting
      • Bladder Cancer Stage I
      • Avoid second resection after initial complete resection
      • Mansoura, Dakahlia, Egypt
        Urology and nephrology center, Mansoura University
      Aug 2, 2023

      Bladder Cancer Trial in Lausanne (Flexible cystoscopy, Urinary catheter)

      Active, not recruiting
      • Bladder Cancer
      • Flexible cystoscopy
      • Urinary catheter
      • Lausanne, VD, Switzerland
        Centre Hospitalier Universitaire Vaudois, CHUV
      Dec 1, 2022

      Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

      Not yet recruiting
      • Bladder Cancer
      • +3 more
      • Geriatric-8 Survey
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2023

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      Analytical Specificity of Bladder EpiCheck Test in Healthy

      Completed
      • Non Muscle Invasive Bladder Cancer
      • Non-Muscle Invasive Bladder Urothelial Carcinoma
      • Bladder EpiCheck
      • San Antonio, Texas
        Urology San Antonio
      Sep 3, 2023

      High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma, Perfusion; Complications, Intraoperative Complications Trial

      Recruiting
      • High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
      • +2 more
      • hyperthermic intravesical perfusion
      • Zhengzhou, Henan, China
        BR-PRG
      Sep 15, 2022

      Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • +2 more
      • PDD-TURBT with hexaminolevulinate (Hexvix®)
      • Power Led Saphira (TM) from KARL STORZ
      • (no location specified)
      Jul 24, 2023

      Avelumab First-Line Maintenance in Canadian People With Advanced

      Not yet recruiting
      • Urinary Bladder Neoplasms
      • +3 more
      • Avelumab first-line maintenance
      • Mississauga, Ontario, Canada
        Bayshore Specialty Rx
      Jan 24, 2023

      Protocol for Muscle Invasive Urothelial Carcinoma of Urinary

      Recruiting
      • Bladder Cancer
      • terta modal bladder preservation
      • Assiut, Assuit, Egypt
        Assuit university
      Aug 13, 2022

      Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

      Completed
      • Urinary Bladder Cancer
      • +4 more
      • Neutrophil to lymphocyte ratio
      • Cairo, Egypt
        Ain Shams university
      Jul 15, 2023

      Urothelial Carcinoma Trial (Disitamab Vedotin, radiotherapy)

      Not yet recruiting
      • Urothelial Carcinoma
      • Disitamab Vedotin
      • radiotherapy
      • (no location specified)
      Jun 20, 2023

      Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

      Active, not recruiting
      • Urinary Bladder Cancer
      • München, Germany
      • +2 more
      Oct 19, 2022

      Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

      Active, not recruiting
      • Muscle Invasive Bladder Cancer
      • Urothelial Carcinoma
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Nov 23, 2022

      Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial

      Not yet recruiting
      • Muscle Invasive Bladder Urothelial Carcinoma
      • +3 more
      • Biospecimen Collection
      • +7 more
      • (no location specified)
      Aug 10, 2023

      Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

      Active, not recruiting
      • Bladder Urothelial Carcinoma
      • +4 more
      • Biopsy
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2022

      CXCL5 asValuable Prognostic Marker in Urinary Bladder Urothelial

      Recruiting
      • Urinary Bladder Urothelial Carcinoma
        • Sohag, Egypt
          Faculty of Medicine, Sohag University
        Jul 26, 2022

        Muscle Invasive Bladder Cancer, HER2 Expression, Radiotherapy Trial in Shanghai (Disitamab Vedotin and Toripalimab)

        Recruiting
        • Muscle Invasive Bladder Cancer
        • +4 more
        • Disitamab Vedotin and Toripalimab
        • Shanghai, Shanghai, China
          Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
        Jul 31, 2023